Viral vectors are widely used in gene therapies. The viral vectors are majorly used by researchers to deliver genetic materials in the cells. Viral vectors are playing significant role in the pharmaceutical sector, as many research and innovations are ongoing for the development of drugs for treating cancer, cardiovascular diseases, ophthalmology, hematology, and many others.
The global Viral Vector and Plasmid DNA Testing Service market was valued at US$ 234.5 million in 2023 and is anticipated to reach US$ 1039.6 million by 2030, witnessing a CAGR of 23.5% during the forecast period 2024-2030.
The Viral Vector and Plasmid DNA Testing Service market is driven by the increasing demand for accurate and reliable testing services to ensure the safety and quality of gene therapies and vaccines using viral vectors and plasmid DNA. Testing services play a crucial role in assessing the potency, purity, and identity of these biopharmaceutical products before clinical use. The growing focus on gene-based therapies and the development of innovative treatments for various diseases contribute to market growth. Moreover, regulatory requirements mandating stringent testing standards further propel adoption. However, challenges include the complexity of testing methods and the need for specialized expertise and equipment. Addressing potential cross-contamination, ensuring consistency in testing results, and adhering to evolving regulatory guidelines are ongoing concerns. The market's success relies on continuous research to develop advanced testing methodologies, robust quality control measures, and collaborations between testing laboratories and pharmaceutical companies to offer accurate, efficient, and compliant viral vector and plasmid DNA testing services while navigating the evolving challenges associated with biopharmaceutical testing.
This report aims to provide a comprehensive presentation of the global market for Viral Vector and Plasmid DNA Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector and Plasmid DNA Testing Service.
Report Scope
The Viral Vector and Plasmid DNA Testing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector and Plasmid DNA Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector and Plasmid DNA Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
Segment by Type
Safety
Genetic Characterization
Purity
Identity
Potency
Segment by Application
Research Organizations
Pharmaceutical
Biotechnological Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector and Plasmid DNA Testing Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Safety
1.2.3 Genetic Characterization
1.2.4 Purity
1.2.5 Identity
1.2.6 Potency
1.3 Market by Application
1.3.1 Global Viral Vector and Plasmid DNA Testing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Organizations
1.3.3 Pharmaceutical
1.3.4 Biotechnological Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector and Plasmid DNA Testing Service Market Perspective (2019-2030)
2.2 Viral Vector and Plasmid DNA Testing Service Growth Trends by Region
2.2.1 Global Viral Vector and Plasmid DNA Testing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector and Plasmid DNA Testing Service Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector and Plasmid DNA Testing Service Market Dynamics
2.3.1 Viral Vector and Plasmid DNA Testing Service Industry Trends
2.3.2 Viral Vector and Plasmid DNA Testing Service Market Drivers
2.3.3 Viral Vector and Plasmid DNA Testing Service Market Challenges
2.3.4 Viral Vector and Plasmid DNA Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector and Plasmid DNA Testing Service Players by Revenue
3.1.1 Global Top Viral Vector and Plasmid DNA Testing Service Players by Revenue (2019-2024)
3.1.2 Global Viral Vector and Plasmid DNA Testing Service Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector and Plasmid DNA Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector and Plasmid DNA Testing Service Revenue
3.4 Global Viral Vector and Plasmid DNA Testing Service Market Concentration Ratio
3.4.1 Global Viral Vector and Plasmid DNA Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector and Plasmid DNA Testing Service Revenue in 2023
3.5 Viral Vector and Plasmid DNA Testing Service Key Players Head office and Area Served
3.6 Key Players Viral Vector and Plasmid DNA Testing Service Product Solution and Service
3.7 Date of Enter into Viral Vector and Plasmid DNA Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector and Plasmid DNA Testing Service Breakdown Data by Type
4.1 Global Viral Vector and Plasmid DNA Testing Service Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Type (2025-2030)
5 Viral Vector and Plasmid DNA Testing Service Breakdown Data by Application
5.1 Global Viral Vector and Plasmid DNA Testing Service Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
6.2 North America Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
6.4 North America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
7.2 Europe Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
7.4 Europe Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
9.2 Latin America Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
9.4 Latin America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vector and Plasmid DNA Testing Service Introduction
11.1.4 BioReliance Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vector and Plasmid DNA Testing Service Introduction
11.2.4 Cobra Biologics Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector and Plasmid DNA Testing Service Introduction
11.4.4 UniQure Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vector and Plasmid DNA Testing Service Introduction
11.5.4 FinVector Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vector and Plasmid DNA Testing Service Introduction
11.6.4 MolMed Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vector and Plasmid DNA Testing Service Introduction
11.7.4 MassBiologics Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vector and Plasmid DNA Testing Service Introduction
11.8.4 Richter-Helm Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vector and Plasmid DNA Testing Service Introduction
11.10.4 Lonza Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vector and Plasmid DNA Testing Service Introduction
11.11.4 Aldevron Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vector and Plasmid DNA Testing Service Introduction
11.12.4 Eurogentec Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vector and Plasmid DNA Testing Service Introduction
11.14.4 Biovian Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.14.5 Biovian Recent Development
11.15 Brammer Bio
11.15.1 Brammer Bio Company Detail
11.15.2 Brammer Bio Business Overview
11.15.3 Brammer Bio Viral Vector and Plasmid DNA Testing Service Introduction
11.15.4 Brammer Bio Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.15.5 Brammer Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
听
听
*If Applicable.
